ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
FRA:ILU - Deutsche Boerse Ag - US4523271090 - Common Stock - Currency: EUR
Taking everything into account, ILU scores 5 out of 10 in our fundamental rating. ILU was compared to 20 industry peers in the Life Sciences Tools & Services industry. ILU has only an average score on both its financial health and profitability. ILU has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ILU was profitable.
ILU had a positive operating cash flow in the past year.
In multiple years ILU reported negative net income over the last 5 years.
Each year in the past 5 years ILU had a positive operating cash flow.
1.2 Ratios
ILU has a worse Return On Assets (-15.61%) than 90.00% of its industry peers.
The Return On Equity of ILU (-40.75%) is worse than 90.00% of its industry peers.
ILU has a Return On Invested Capital of 13.57%. This is amongst the best in the industry. ILU outperforms 95.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.61% | ||
| ROE | -40.75% | ||
| ROIC | 13.57% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Operating Margin value of 21.07%, ILU belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
ILU's Operating Margin has declined in the last couple of years.
ILU has a Gross Margin of 66.34%. This is amongst the best in the industry. ILU outperforms 95.00% of its industry peers.
ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.07% | ||
| PM (TTM) | N/A | ||
| GM | 66.34% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
ILU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ILU has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ILU has more shares outstanding
The debt/assets ratio for ILU is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.54 indicates that ILU is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.54, ILU is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
The Debt to FCF ratio of ILU is 2.27, which is a good value as it means it would take ILU, 2.27 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.27, ILU belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
A Debt/Equity ratio of 0.63 indicates that ILU is somewhat dependend on debt financing.
ILU's Debt to Equity ratio of 0.63 is in line compared to the rest of the industry. ILU outperforms 45.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for ILU, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 2.27 | ||
| Altman-Z | 3.54 |
ROIC/WACC1.33
WACC10.24%
2.3 Liquidity
ILU has a Current Ratio of 1.86. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.86, ILU is doing good in the industry, outperforming 65.00% of the companies in the same industry.
ILU has a Quick Ratio of 1.48. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
ILU has a better Quick ratio (1.48) than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.86 | ||
| Quick Ratio | 1.48 |
3. Growth
3.1 Past
ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 352.17%, which is quite impressive.
ILU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.93% yearly.
The Revenue has decreased by -3.27% in the past year.
The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)352.17%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%230.56%
Revenue 1Y (TTM)-3.27%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-4.77%
3.2 Future
ILU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.99% yearly.
The Revenue is expected to grow by 3.86% on average over the next years.
EPS Next Y76.16%
EPS Next 2Y39.25%
EPS Next 3Y30.79%
EPS Next 5Y21.99%
Revenue Next Year-2.11%
Revenue Next 2Y0.31%
Revenue Next 3Y2.38%
Revenue Next 5Y3.86%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 23.45, which indicates a rather expensive current valuation of ILU.
65.00% of the companies in the same industry are more expensive than ILU, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.73, ILU is valued at the same level.
With a Price/Forward Earnings ratio of 20.53, ILU is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ILU is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ILU to the average of the S&P500 Index (34.61), we can say ILU is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.45 | ||
| Fwd PE | 20.53 |
4.2 Price Multiples
75.00% of the companies in the same industry are more expensive than ILU, based on the Enterprise Value to EBITDA ratio.
ILU's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ILU is cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.63 | ||
| EV/EBITDA | 12.72 |
4.3 Compensation for Growth
ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ILU's earnings are expected to grow with 30.79% in the coming years.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y39.25%
EPS Next 3Y30.79%
5. Dividend
5.1 Amount
No dividends for ILU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (8/12/2025, 7:00:00 PM)
83.94
+2.39 (+2.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners101.51%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap13.29B
Analysts72
Price Target99.59 (18.64%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.22%
Min EPS beat(2)-7.76%
Max EPS beat(2)1.33%
EPS beat(4)2
Avg EPS beat(4)-10.12%
Min EPS beat(4)-60.91%
Max EPS beat(4)26.88%
EPS beat(8)6
Avg EPS beat(8)314.25%
EPS beat(12)9
Avg EPS beat(12)229.49%
EPS beat(16)13
Avg EPS beat(16)180.02%
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)-0.18%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.91%
Revenue beat(8)3
Avg Revenue beat(8)-0.59%
Revenue beat(12)4
Avg Revenue beat(12)-1.16%
Revenue beat(16)7
Avg Revenue beat(16)0.05%
PT rev (1m)3.75%
PT rev (3m)-3.2%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-7.59%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.45 | ||
| Fwd PE | 20.53 | ||
| P/S | 3.56 | ||
| P/FCF | 17.63 | ||
| P/OCF | 15.44 | ||
| P/B | 6.52 | ||
| P/tB | 15.81 | ||
| EV/EBITDA | 12.72 |
EPS(TTM)3.58
EY4.26%
EPS(NY)4.09
Fwd EY4.87%
FCF(TTM)4.76
FCFY5.67%
OCF(TTM)5.44
OCFY6.48%
SpS23.57
BVpS12.87
TBVpS5.31
PEG (NY)0.31
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.61% | ||
| ROE | -40.75% | ||
| ROCE | 19.27% | ||
| ROIC | 13.57% | ||
| ROICexc | 18.36% | ||
| ROICexgc | 30.44% | ||
| OM | 21.07% | ||
| PM (TTM) | N/A | ||
| GM | 66.34% | ||
| FCFM | 20.2% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 2.27 | ||
| Debt/EBITDA | 1.21 | ||
| Cap/Depr | 39.37% | ||
| Cap/Sales | 2.86% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.37% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.86 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 3.54 |
F-Score6
WACC10.24%
ROIC/WACC1.33
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)352.17%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%230.56%
EPS Next Y76.16%
EPS Next 2Y39.25%
EPS Next 3Y30.79%
EPS Next 5Y21.99%
Revenue 1Y (TTM)-3.27%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-4.77%
Revenue Next Year-2.11%
Revenue Next 2Y0.31%
Revenue Next 3Y2.38%
Revenue Next 5Y3.86%
EBIT growth 1Y1675.86%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year30.52%
EBIT Next 3Y15.06%
EBIT Next 5Y12.66%
FCF growth 1Y484.21%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y334.78%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%